Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 9/20 | 0.46 |
| ▸ | LPL | P06858 | 8/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.46 |
| ▸ | MGLL | Q99685 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 3/20 | 0.35 |
| ▸ | CNR2 | P34972 | 3/20 | 0.35 |
| ▸ | MMP2 | P08253 | 2/20 | 0.33 |
| ▸ | MMP9 | P14780 | 2/20 | 0.33 |
| ▸ | MMP8 | P22894 | 2/20 | 0.33 |
| ▸ | MMP13 | P45452 | 2/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.33 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5809203 | 1.00 | LIPG (0.46) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL29383962 | 1.00 | LIPG (0.46) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL766656 | 1.00 | LIPG (0.46) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL28537539 | 1.00 | LIPG (0.46) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL29460237 | 1.00 | LIPG (0.46) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL29453590 | 1.00 | LIPG (0.46) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL371497 | 1.00 | LIPG (0.46) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL6446324 | 0.98 | LIPG (0.45) | LIPGLPLTRPV1MGLLCA1 | |
| Ethylene Glycol SCHEMBL588016 | 0.96 | LIPG (0.43) | LIPGLPLTRPV1MGLLCA1 | |
| 1,3-Propanediol SCHEMBL23298331 | 0.94 | LIPG (0.42) | LIPGLPLTRPV1MGLLCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111349217-B | Ternary copolymer and preparation method of electric storage device thereof | 黑龙江大学 | 2023-06-27 | — | — | CN | claimed |
| CN-113549196-B | Fluorenyl conjugated polymer and preparation method of electric storage device thereof | 黑龙江大学 | 2022-09-02 | — | — | CN | claimed |
| CN-114072446-A | Polymer dots | 生物辐射实验室股份有限公司 | 2022-02-18 | — | — | CN | claimed |
| CN-111689994-A | Organic conjugated molecular material with bifluorene Aza-BODIPY as basic skeleton and preparation method and application thereof | 安徽师范大学 | 2020-09-22 | — | — | CN | claimed |
| US-8361484-B2 | Polymer systems for lung volume reduction therapy | AERIS THERAPEUTICS, INC. (US) | 2013-01-29 | — | — | US | claimed |
| US-20100040538-A1 | Polymer Systems for Lung Volume Reduction Therapy | CANADIAN IMPERIAL BANK OF COMMERCE (CA) | 2010-02-18 | — | — | US | claimed |
| EP-2059227-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | Aeris Therapeutics, Inc. (US) | 2009-05-20 | — | — | EP | claimed |
| WO-2008039827-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | AERIS THERAPEUTICS, INC. (US) | 2008-04-03 | — | — | WO | claimed |
| EP-3169722-B9 | NANOPARTICLES | CHROMITION LTD (GB) | 2025-06-18 | — | — | EP | disclosed |
| EP-3169722-B1 | NANOPARTICLES | CHROMITION LTD (GB) | 2025-02-12 | — | — | EP | disclosed |
| US-20230143779-A1 | ORGANIC SOLID-STATE LASER, COMPOUND AND USE THEREOF | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2023-05-11 | — | — | US | disclosed |
| US-11596697-B2 | Nanoparticle conjugates | CHROMITION LIMITED (GB) | 2023-03-07 | — | — | US | disclosed |
| CN-105637347-B | Fluorinated polymer dots | 华盛顿大学商业中心 | 2022-09-06 | — | — | CN | disclosed |
| CN-113549196-B | Fluorenyl conjugated polymer and preparation method of electric storage device thereof | 黑龙江大学 | 2022-09-02 | — | — | CN | disclosed |
| EP-1213336-A2 | Polymeric fluorescent substance and polymer light-emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-06-12 | — | — | EP | disclosed |
| EP-1062703-A1 | ELECTROLUMINESCENT DEVICES | Cambridge Display Technology Limited (GB) | 2000-12-27 | — | — | EP | disclosed |
| EP-1025142-A1 | PROCESS FOR PREPARING CONJUGATED POLYMERS | THE DOW CHEMICAL COMPANY (US) | 2000-08-09 | — | — | EP | disclosed |
| WO-1999048160-A1 | ELECTROLUMINESCENT DEVICES | CAMBRIDGE DISPLAY TECHNOLOGY LTD. (GB) | 1999-09-23 | — | — | WO | disclosed |
| WO-1999020675-A1 | PROCESS FOR PREPARING CONJUGATED POLYMERS | THE DOW CHEMICAL COMPANY (US) | 1999-04-29 | — | — | WO | disclosed |
| US-5777070-A | Process for preparing conjugated polymers | THE DOW CHEMICAL COMPANY (US) | 1998-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230143779-A1 | ORGANIC SOLID-STATE LASER, COMPOUND AND USE THEREOF | LEF1, CCNT1, CCNT2 | LIPG 2480/4885LPL 1506/4885TRPV1 662/4885 |
| US-11596697-B2 | Nanoparticle conjugates | CD47, CLTB, LCP1 | LIPG 2064/4885LPL 4497/4885TRPV1 3706/4885 |
| US-20100040538-A1 | Polymer Systems for Lung Volume Reduction Therapy | GFER, MUC1, CTH | LIPG 1131/4885LPL 3998/4885TRPV1 2974/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.